Clinical characteristics of patients with a periorbital mass after autologous fat injection for facial augmentation and short-term outcomes of steroid treatment

Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS
Saem LeeHye Sun Choi

Abstract

The aim of this study was to evaluate the clinical features of patients with a periorbital palpable mass or swelling after autologous fat injection for facial augmentation. This retrospective case study included 50 patients who developed a periorbital palpable mass or swelling after undergoing autologous fat injection for facial augmentation performed by various plastic surgeons. The patients' medical records were reviewed for clinical history, radiological findings, and treatment outcomes. All patients were female with a mean age of 43.18 ± 12.04 (range, 19-63) years. After fat injection, the average time of symptom onset was 9.09 ± 8.45 (1-36) months, and the mean follow-up duration was 13 ± 1 (4-36) weeks. Majority of patients complained of eyelid swelling or periorbital palpable mass. All patients had received fat injection in the forehead area, except for the following patients: Five patients who were unaware of the site of fat injection and one patient who had received the injection in the upper eyelid area with simultaneous double-fold surgery. In addition, 39 patients had received a second injection of cryopreserved autologous fat tissue. Forty-five patients developed a mass in the upper eyelid area, four were found to ...Continue Reading

References

Sep 1, 1995·American Journal of Otolaryngology·S LangG Grevers
Apr 1, 1997·Clinics in Plastic Surgery·S R Coleman
Dec 3, 2003·Aesthetic Plastic Surgery·Gottfried LemperleUlrich Charrier
Jan 19, 2006·Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.]·David K MoscatelloNaomi Lawrence
Dec 1, 2006·Dermatology : International Journal for Clinical and Investigative Dermatology·Dolores WolframHildegunde Piza-Katzer
May 24, 2007·Plastic and Reconstructive Surgery·Matthew R KaufmanJames P Bradley
Sep 4, 2008·Plastic and Reconstructive Surgery·Lee L Q PuHenry C Vasconez
Dec 10, 2013·Canadian Journal of Ophthalmology. Journal Canadien D'ophtalmologie·Yi Ryeung ParkTae Yoon La

❮ Previous
Next ❯

Citations

Jul 20, 2016·Infection & chemotherapy·Sun Hee ParkJung-Hyun Choi
Mar 20, 2018·The Journal of Craniofacial Surgery·Ji Sun BaekHye Sun Choi
Jan 8, 2019·The Journal of Craniofacial Surgery·Jungah HuhSehyun Baek
Mar 4, 2020·Archives of Craniofacial Surgery·Hyee Jae Yang, Sang Yoon Kang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.